Ascentis Independent Advisors purchased a new stake in shares of Cigna Group (NYSE:CI – Free Report) in the 1st quarter, Holdings Channel reports. The fund purchased 1,964 shares of the health services provider’s stock, valued at approximately $524,000.
A number of other institutional investors also recently bought and sold shares of the stock. Cary Street Partners Investment Advisory LLC grew its stake in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares during the period. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares in the last quarter. IHT Wealth Management LLC increased its holdings in shares of Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after buying an additional 38 shares during the last quarter. Whetstone Capital Advisors LLC lifted its position in Cigna Group by 4.9% in the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after buying an additional 39 shares during the last quarter. Finally, CYBER HORNET ETFs LLC raised its position in Cigna Group by 5.3% in the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares during the period. 86.99% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on CI shares. Mizuho upped their price objective on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Royal Bank Of Canada raised their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Finally, Morgan Stanley raised their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $338.80.
Cigna Group Price Performance
Shares of CI stock opened at $289.89 on Thursday. The stock’s 50-day moving average is $285.51 and its 200 day moving average is $279.50. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $76.68 billion, a P/E ratio of 12.29, a PEG ratio of 1.10 and a beta of 0.29.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.45%.
Insiders Place Their Bets
In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
